5-{5-(benzylthio)-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl}-2-chloropyridine

Catalog No. :
ACCXCF677
CAS No. :
680216-97-1
Molecular Formula :
C21H14ClF3N4S
Molecular Weight :
446.89

IUPAC Name:5-(5-(benzylthio)-4-(3-(trifluoromethyl)phenyl)-4H-1,2,4-triazol-3-yl)-2-chloropyridine

5-{5-(benzylthio)-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl}-2-chloropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-{5-(benzylthio)-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl}-2-chloropyridine
IUPAC Name5-(5-(benzylthio)-4-(3-(trifluoromethyl)phenyl)-4H-1,2,4-triazol-3-yl)-2-chloropyridine
MDL No.MFCD00275143
Molecular FormulaC21H14ClF3N4S
Molecular Weight446.89
SMILESClC1=NC=C(C2=NN=C(SCC3=CC=CC=C3)N2C4=CC=CC(C(F)(F)F)=C4)C=C1
InChI KeyJKMWNDKDRVSUDS-UHFFFAOYSA-N
SynonymPyridine, 2-chloro-5-[5-[(phenylmethyl)thio]-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl]-
CAS No.680216-97-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCXCF677 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEMHZ217 route compound structure diagram
    ACEMHZ217444120-91-6 In Stock
  4. Then
  5. ACCXCF677 route product structure diagram
    ACCXCF677680216-97-1
Inquiry

2. ACCXCF677 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCXCF677 route product structure diagram
    ACCXCF677680216-97-1
Inquiry

Comments (0)